BioCentury
ARTICLE | Clinical News

Thymoglobulin: Began Phase III trial

August 15, 1994 7:00 AM UTC

SangStat (SANG), Menlo Park, Calif. Product: Thymoglobulin, a polyclonal rabbit anti-thymocyte antibody reactive with T cells Indication: Acute organ rejection Status: Began Phase III trial in 200 ki...